The Neuro-Oncology Program at Children’s Hospital of Philadelphia is staffed by a group of seven full-time, dedicated pediatric neuro-oncologists, and is one of the largest such groups dedicated to treating pediatric brain and spinal cord tumors, neurofibromatosis and associated tumors.

Meet the Childrens Hospital of Philadelphia’s Team

Dr. Jane
Minturn

Lead Investigator

Dr. Mateusz Koptyra

Lead Investigator

Sonora Reingruber

Tissue Navigator

Beth
Frenkel

GFAC/CBTN Manager of Post-Mortem Operations

Our Regional Center of Excellence at CHOP

Children’s Hospital of Philadelphia (CHOP) was the nation’s first hospital devoted exclusively to the care of children. Since our start in 1855, CHOP has been the birthplace for countless breakthroughs and dramatic firsts in pediatric medicine. Built on a foundation of delivering safe, high-quality, family-centered care, the Hospital has fostered medical discoveries and innovations that have improved pediatric healthcare and saved countless children’s lives. Today, families facing complex conditions come to CHOP from all over the world, and our compassionate care and innovation has repeatedly earned us a spot on the U.S. News & World Report’s Honor Roll of the nation’s best children’s hospitals.

The Center for Data-Driven Discovery in Biomedicine (D3b) is a translational biomedical research Center at Children’s Hospital of Philadelphia, which brings together expertise across disciplines to accelerate bench-to-bedside research on behalf of children. The D3b Center is founded on convergence research principles that define its partnership with other leading researchers, clinicians, and patient advocates, spanning across areas of expertise, across institutions, and across the globe — to collaboratively generate the quantity and quality of information and increased understanding needed to accelerate discoveries and improve treatments for pediatric diseases.

D3b’s open-science model allows the Center to securely generate and integrate large volumes of complex genomic, clinical, and patient data, supported by open-access, D3b-developed platforms that empower collaborative discovery. In addition to its clinical and scientific collaborations, D3b is a champion of the patient community, working alongside more than 50 nonprofit foundations and patient advocates.